ZSP-1601 | Interleukin Related interleukin-related.com

Product Name :
ZSP-1601

Search keywords :
PDE2A

drugId :
null

Target Vo:
Phosphodiesterase 2A

Target Vo Short Name :
PDE2A

Moa_Name:
Phosphodiesterase 2A inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Guangdong Zhongsheng Pharmaceutical Co Ltd

Active Company_Name :
Guangdong Raynovent Biotech Co Ltd

Active Indication_Name:
Metabolic Dysfunction-Associated Steatotic Liver Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ATG7 Antibody
Fatty Acid Synthase Antibody
Keap1 Antibody: Keap1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to Keap1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts